发明名称 |
Human lymphocyte vaccine adjuvant |
摘要 |
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes. |
申请公布号 |
US8088397(B2) |
申请公布日期 |
2012.01.03 |
申请号 |
US20100824577 |
申请日期 |
2010.06.28 |
申请人 |
HASUMI KENICHIRO;MANN DEAN LEMAR;HANKEY KIM GRAULICH;HOLT KRISTINA MICHELLE;HASUMI, LLC;UNIVERSITY OF MARYLAND, BALTIMORE |
发明人 |
HASUMI KENICHIRO;MANN DEAN LEMAR;HANKEY KIM GRAULICH;HOLT KRISTINA MICHELLE |
分类号 |
A61K45/00;A61K;A61K6/00;A61K39/00;A61K39/21;A61K39/29;A61K39/39;C12Q1/00;G01N33/00 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|